Cargando…
RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis
Up to now, the chemotherapy approaches for glioblastoma were limited. 1-[2-Thiazolylazo]-2-naphthol (named as NSC139021) was shown to significantly inhibit the proliferation of prostate cancer cells by targeting the atypical protein kinase RIOK2. It is documented that RIOK2 overexpressed in glioblas...
Autores principales: | Yu, Min, Hu, Xiaoyan, Yan, Jingyu, Wang, Ying, Lu, Fei, Chang, Junlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470931/ https://www.ncbi.nlm.nih.gov/pubmed/34572430 http://dx.doi.org/10.3390/biomedicines9091244 |
Ejemplares similares
-
First Evidence of Function for Schistosoma japonicum
riok-1 and RIOK-1
por: Mughal, Mudassar N., et al.
Publicado: (2021) -
Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma
por: Gousias, Konstantinos, et al.
Publicado: (2022) -
A Derivate of Benzimidazole-Isoquinolinone Induces SKP2 Transcriptional Inhibition to Exert Anti-Tumor Activity in Glioblastoma Cells
por: Chen, He-ying, et al.
Publicado: (2019) -
Crystal structure of human RIOK2 bound to a specific inhibitor
por: Wang, Jing, et al.
Publicado: (2019) -
The p27–Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells
por: Kullmann, Michael K, et al.
Publicado: (2013)